乙酸性食道炎中的乙酸细胞分布及其对疾病活动及其对治疗反应的影响
Anne Godat1, Ralph Mueller2, Désirée Schenker3
1Department of Internal Medicine, GZO Zurich Regional Health Center, Wetzikon, Switzerland.
概括
性食道炎 (EOE) 炎症模式各不相同,可能会影响治疗结果. 这项研究调查了在食道中的乙酸细胞分布如何影响EoE呈现和对治疗的反应.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 生性食道炎 (EoE) 的特征是食道的生性食道,通常集中在远部.
- 埃奥斯诺菲尔在EoE中的分布通常不均.
- 埃奥西诺菲尔分布对EoE严重程度和治疗反应的影响尚不清楚.
研究的目的:
- 为了表征异性食道炎的不同炎症模式.
- 调查这些模式与疾病表现之间的关联.
- 确定炎症模式对EoE治疗结果的影响.
主要方法:
- 对食道活检的组织病理学分析,以确定炎症模式.
- 确定模式与临床表现和患者报告结果的相关性.
- 根据炎症模式评估治疗反应.
主要成果:
- 在远端突出之外的EoE中确定了不同的炎症模式.
- 在特定的炎症模式和疾病严重程度之间显示出显著的关联.
- 观察到与明显的eosinophilic分布相关的差异性治疗反应.
结论:
- 消化道中氨基酸的分布模式在EoE中异质.
- 炎症模式显著影响EoE表现和临床过程.
- 了解这些模式对于预测和优化EOE治疗反应至关重要.
相关概念视频
Barrett Esophagus-II: Clinical Manifestations and Management
157
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
157
Gastroesophageal Reflux Disease II: Clinical Features and Management
88
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
88
Barrett Esophagus-I: Introduction
99
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
99
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
305
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
305
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K


